Rather, reverse-engineering a biomarker present in ECFCs that is also found in its precursor, PBMCs would be more useful and highly significant for patients at-risk of developing CAD. 5.2.
← all excerpts
Novel Strategies in the Early Detection and Treatment of Endothelial Cell-Specific Mitochondrial Dysfunction in Coronary Artery Disease.
1
—
—